Open Access

2022 ESC Guidelines on cardio-oncology

Event: ESC Congress 2022
Topic: Cardio-Oncology
Session type: New ESC Guidelines
Date: 27 August 2022
Time: 11:15 - 12:15

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

4 presentations in this session

Cardiovascular toxicity risk stratification before anticancer therapy.

Speaker: Doctor E. de Azambuja (Brussels, BE)
Thumbnail

Prevention and monitoring of cardiovascular complications during cancer therapy.

Speaker: Professor J. Bergler-Klein (Vienna, AT)
Thumbnail

Diagnosis and management of acute and subacute CVDs in patients with active cancer.

Speaker: Associate Professor D. Farmakis (Athens, GR)
Thumbnail

End-of-cancer therapy cardiovascular risk assessment and long-term follow-up.

Speaker: Professor T. Suter (Bern, CH)
Thumbnail

4 speakers from this session

Doctor Evandro de Azambuja

Jules Bordet Institute, Brussels (Belgium)
1 presentation
3 followers

Professor Jutta Bergler-Klein

Medical University of Vienna, Vienna (Austria)
12 presentations
4 followers

Associate Professor Dimitrios T Farmakis

National & Kapodistrian University of Athens Medical School, Athens (Greece)
16 presentations
1 follower

Professor Thomas Suter

Bern University Hospital, Inselspital, Bern (Switzerland)
15 presentations
4 followers

This platform is supported by

logo Novo Nordisk